CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851623397
- Phone
- 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-26 | Merck KGaA 10% owner | Conversion | +416,060 | 416,060 | ||
| 2021-10-26 | Merck KGaA 10% owner | Conversion | +264,765 | 680,825 | ||
| 2021-10-26 | Merck KGaA 10% owner | Conversion · Series B Preferred Stock | −3,952,568 | 0 | ||
| 2021-10-26 | Merck KGaA 10% owner | Conversion · Series C Preferred Srock | −2,515,271 | 0 |
Page 12 of 12 · 224 trades